EP0889725A4 - Methode de traitement des troubles bipolaires - Google Patents

Methode de traitement des troubles bipolaires

Info

Publication number
EP0889725A4
EP0889725A4 EP96944772A EP96944772A EP0889725A4 EP 0889725 A4 EP0889725 A4 EP 0889725A4 EP 96944772 A EP96944772 A EP 96944772A EP 96944772 A EP96944772 A EP 96944772A EP 0889725 A4 EP0889725 A4 EP 0889725A4
Authority
EP
European Patent Office
Prior art keywords
bipolar disorder
treating bipolar
treating
disorder
bipolar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96944772A
Other languages
German (de)
English (en)
Other versions
EP0889725A1 (fr
Inventor
Charles M Beasley Jr
Gary D Tollefson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of EP0889725A1 publication Critical patent/EP0889725A1/fr
Publication of EP0889725A4 publication Critical patent/EP0889725A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
EP96944772A 1996-03-11 1996-12-04 Methode de traitement des troubles bipolaires Withdrawn EP0889725A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1315996P 1996-03-11 1996-03-11
US13159P 1996-03-11
PCT/US1996/019575 WO1997033577A1 (fr) 1996-03-11 1996-12-04 Methode de traitement des troubles bipolaires

Publications (2)

Publication Number Publication Date
EP0889725A1 EP0889725A1 (fr) 1999-01-13
EP0889725A4 true EP0889725A4 (fr) 2000-01-19

Family

ID=21758606

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96944772A Withdrawn EP0889725A4 (fr) 1996-03-11 1996-12-04 Methode de traitement des troubles bipolaires

Country Status (15)

Country Link
EP (1) EP0889725A4 (fr)
JP (1) JP2000506859A (fr)
KR (1) KR19990087713A (fr)
CN (1) CN1213966A (fr)
AU (1) AU734011B2 (fr)
BR (1) BR9612548A (fr)
CZ (1) CZ290298A3 (fr)
EA (1) EA000758B1 (fr)
HU (1) HUP9903679A3 (fr)
IL (1) IL126162A0 (fr)
NO (1) NO984189L (fr)
NZ (1) NZ326031A (fr)
PL (1) PL328925A1 (fr)
TR (1) TR199801797T2 (fr)
WO (1) WO1997033577A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
MY127938A (en) * 1998-05-22 2007-01-31 Lilly Co Eli Combinatin therapy for treatment of partial responders or refractory depression
CZ20004280A3 (cs) * 1998-05-29 2001-09-12 Eli Lilly And Company Lék pro léčbu bipolárních poruch a farmaceutický prostředek
WO2000030649A1 (fr) * 1998-11-23 2000-06-02 Sepracor Inc. Compositions pharmaceutiques contenant de l'olanzapine-n-oxyde
DE69923081T2 (de) 1998-11-23 2005-12-08 Sepracor Inc., Marlborough Desmethylolanzapine enthaltende zusammensetzungen und verfahren
AU757874B2 (en) 1998-11-23 2003-03-06 Sepracor, Inc. 2-hydroxymethylolanzapine compositions and methods
CA2891122C (fr) 2012-11-14 2021-07-20 The Johns Hopkins University Methodes et compositions pour le traitement de la schizophrenie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
B K PURI ET AL: "Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder", BRITISH JOURNAL OF CLINICAL PRACTICE, vol. 49, no. 6, 1995, pages 333 - 334, XP002122087 *
C A ZARATE ET AL: "Clozapine in severe mood disorders", THE JOURNAL OF CLINICAL PSYCHIATRY, vol. 56, no. 9, September 1995 (1995-09-01), pages 411 - 417, XP002122086 *
D C FUCHS: "Clozapine treatment of bipolar disorder in a young adolescent", CHILD & ADOLESCENT PSYCHIATRY, vol. 33, no. 9, 1994, pages 1299 - 1302, XP002122088 *
R W BAKER ET AL: "Olanzapine's impact on depressive and obsessive compulsive symptoms in schizophrenia", PSYCHOPHARMACOLOGY BULLETIN, vol. 31, no. 3, 1995, pages 549, XP002122084 *
S L MCELROY ET AL: "Mania, Psychosis and Antipsychotics", J CLIN PSYCHIATRY, vol. 57 (SUPPL 3), 1996, pages 14 - 26, XP002122473 *
See also references of WO9733577A1 *
T SUPPES ET AL: "Clozapine in the treatment of dysphoric mania", BIOLOGICAL PSYCHIATRY, vol. 32, no. 3, 1 August 1992 (1992-08-01), pages 270 - 280, XP002122085 *

Also Published As

Publication number Publication date
TR199801797T2 (xx) 1998-12-21
AU1330797A (en) 1997-10-01
HUP9903679A2 (hu) 2000-04-28
AU734011B2 (en) 2001-05-31
EA199800819A1 (ru) 1999-02-25
PL328925A1 (en) 1999-03-01
JP2000506859A (ja) 2000-06-06
CZ290298A3 (cs) 1999-10-13
BR9612548A (pt) 1999-07-20
HUP9903679A3 (en) 2001-10-29
KR19990087713A (ko) 1999-12-27
NZ326031A (en) 2001-05-25
NO984189D0 (no) 1998-09-11
IL126162A0 (en) 1999-05-09
EA000758B1 (ru) 2000-04-24
CN1213966A (zh) 1999-04-14
WO1997033577A1 (fr) 1997-09-18
EP0889725A1 (fr) 1999-01-13
NO984189L (no) 1998-09-11

Similar Documents

Publication Publication Date Title
IL126203A0 (en) Method for treating pain
EP0906104A4 (fr) Procede de traitement de la douleur
AU1527897A (en) Method for treating the prostate
AU3813397A (en) Apparatus for treating chondromalicia
GB2323699B (en) Editing apparatus, editing system and editing method
ZA973707B (en) Method for treating inflammation.
IL126064A0 (en) Method for treating pain
GB9605828D0 (en) Treatment method
PL328964A1 (en) Acne treating method
IL126063A0 (en) Method for treating migraine pain
EP0956025A4 (fr) Methode d'immunosuppression
IL126162A0 (en) Method for treating bipolar disorder
EP1009403A4 (fr) Traitement de la schizophrenie
SG64990A1 (en) Method of treating polyolefin
IL124786A0 (en) Method for treating pain
EP0904083A4 (fr) Methode d'anesthesie
GB9605709D0 (en) Method
ZA971899B (en) Method for treating insomnia
IL126657A0 (en) Method for treating or preventing ischemia-reperfusion injury
GB9606619D0 (en) Method for treating bipolar disorder
EP1043994A4 (fr) Methode de traitement de la sclerose en plaques
GB9605482D0 (en) Method
GB9606614D0 (en) Method for treating obsessive-compulsive disorder
SI0667175T1 (en) Method for treating edges of skis etc.
IL126160A0 (en) Method for treating insomnia

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980911

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 980911;LT PAYMENT 980911;LV PAYMENT 980911;SI PAYMENT 980911

A4 Supplementary search report drawn up and despatched

Effective date: 19991203

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20001025

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020927